subscribeSubscribe
price-trendAsk Us
Takeda to stop making parathyroid drug Natpara after production challenges

Takeda to stop making parathyroid drug Natpara after production challenges
BIOPHARMADIVE
05 Oct 2022
Share Share
Takeda`s rare disease unit suffers on hemophilia, Natpara recall

Takeda`s rare disease unit suffers on hemophilia, Natpara recall
Angus Liu FIERCE PHARMA
01 Nov 2019
Share Share
Enforcement Report - Week of October 2, 2019

Enforcement Report - Week of October 2, 2019
FDA
02 Oct 2019
Share Share
Rhetoric or a real threat? Track your pharma politics here

Rhetoric or a real threat? Track your pharma politics here
Eric Sagonowsky FIERCE PHARMA
16 Sep 2019
Share Share
Takeda recalls eye drug Natpara, warns patients not to abruptly stop treatment 

Takeda recalls eye drug Natpara, warns patients not to abruptly stop treatment 
Eric Palmer FIERCEPHARMA
07 Sep 2019
Share Share
Takeda Issues US Recall of NATPARA® (parathyroid hormone)

Takeda Issues US Recall of NATPARA® (parathyroid hormone)
FDA
06 Sep 2019
Share Share
Nps Pharms` Natpara(Parathyroid Hormone) Receives Approval in US

Nps Pharms` Natpara(Parathyroid Hormone) Receives Approval in US
FDA
17 Dec 2018
Share Share
NPS Pharms` Biological Parathyroid Hormone Receives Supplemental Approval in US

NPS Pharms` Biological Parathyroid Hormone Receives Supplemental Approval in US
FDA
01 Oct 2018
Share Share
Takeda Is Said to Weigh Sale of Shire Eye Drug to Cut Debt

Takeda Is Said to Weigh Sale of Shire Eye Drug to Cut Debt
Dinesh Nair BLOOMBERG
14 Sep 2018
Share Share
Takeda weighs sale of Shire`s eye care business to cut debt- Bloomberg

Takeda weighs sale of Shire`s eye care business to cut debt- Bloomberg
Sai Sachin Ravikumar CNBC
13 Sep 2018
Share Share